Susquehanna International Group, LLP Fate Therapeutics Inc Put Options Transaction History

Susquehanna International Group, LLP

  • $688 Billion
  • Q2 2025

Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2024

May 07, 2024
BUY
$3.54 - $8.35 $138,060 - $325,650
39,000 New
39,000 $286,000
Q2 2023

Aug 11, 2023
BUY
$4.76 - $6.59 $102,340 - $141,685
21,500 Added 208.74%
31,800 $151,000
Q1 2023

May 16, 2023
BUY
$4.24 - $11.12 $43,672 - $114,535
10,300 New
10,300 $58,000
Q3 2022

Nov 14, 2022
SELL
$21.04 - $36.06 $1.77 Million - $3.04 Million
-84,300 Reduced 87.36%
12,200 $273,000

Others Institutions Holding FATE

# of Institutions
151
Shares Held
83.3M
Call Options Held
179K
Put Options Held
13.4K
View Full List

About FATE THERAPEUTICS INC

FATE Quotes by TradingView
  • Ticker FATE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,000,304
  • Market Cap $146M
  • Description
  • Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...
More about FATE
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email